EntreMed signs manufacturing agreement for Angiostatin in preparation for phase I trials July 21, 1999
Phase II trial results in colorectal and lung cancers support efficacy and tolerability of S-1 July 21, 1999
Preclinical activity, current status of potent P-glycoprotein inhibitor discussed at congress July 19, 1999
RSS